Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | JNK-IN-8 | 3.0 | uM | 3 | MIG | 20.0 | 66 | ||||
N2586 | 3 | MIG | 54.5 | 70 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | MIG | 57.0 | 65 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | MIG | 44.0 | 56 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | MIG | 87.0 | 67 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | MIG | 45.0 | 62 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | MIG | 34.0 | 71 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 3 | MIG | 41.0 | 54 | ||||
RA2159 | IL-17A | 100 | ng/mL | 3 | MIG | 18.0 | 69 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | MIG | 17.0 | 83 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | MIG | 19.5 | 72 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | MIG | 17.0 | 53 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | MIG | 19.0 | 69 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | MIG | 20.5 | 52 | |
N2586 | IL-17A | 100 | ng/mL | 3 | MIG | 57.0 | 51 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | MIG | 60.0 | 55 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | MIG | 43.0 | 50 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | MIG | 94.0 | 55 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | MIG | 35.0 | 66 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | MIG | 34.0 | 49 | |
RA2159 | IL-6 | 100 | ug/mL | 3 | MIG | 15.0 | 59 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | MIG | 19.0 | 63 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | MIG | 16.0 | 61 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | MIG | 18.0 | 53 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | MIG | 17.0 | 62 |